DiaMedica Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2024

	March 31, 2024
Common shares issuable upon exercise of employee and non-employee stock options		4,259,763
Common shares issuable upon settlement of deferred stock units		284,886
Common shares issuable upon vesting and settlement of restricted stock units		17,744
Shares available for grant under the Amended and Restated 2019 Omnibus Incentive Plan		732,574
Shares available for grant under the 2021 Employment Inducement Incentive Plan		110,000
Total		5,404,967